QQQ   423.38 (-0.58%)
AAPL   167.20 (-0.48%)
MSFT   405.19 (-1.61%)
META   503.38 (+1.86%)
GOOGL   156.45 (+0.63%)
AMZN   179.55 (-0.95%)
TSLA   150.45 (-3.22%)
NVDA   849.20 (+1.05%)
AMD   154.94 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.96 (+0.20%)
T   16.31 (+1.18%)
F   12.05 (+0.08%)
MU   112.52 (-3.28%)
GE   153.77 (-1.22%)
CGC   7.87 (+21.26%)
DIS   112.76 (-0.16%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.08 (-1.87%)
XOM   118.72 (+0.08%)
QQQ   423.38 (-0.58%)
AAPL   167.20 (-0.48%)
MSFT   405.19 (-1.61%)
META   503.38 (+1.86%)
GOOGL   156.45 (+0.63%)
AMZN   179.55 (-0.95%)
TSLA   150.45 (-3.22%)
NVDA   849.20 (+1.05%)
AMD   154.94 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.96 (+0.20%)
T   16.31 (+1.18%)
F   12.05 (+0.08%)
MU   112.52 (-3.28%)
GE   153.77 (-1.22%)
CGC   7.87 (+21.26%)
DIS   112.76 (-0.16%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.08 (-1.87%)
XOM   118.72 (+0.08%)
QQQ   423.38 (-0.58%)
AAPL   167.20 (-0.48%)
MSFT   405.19 (-1.61%)
META   503.38 (+1.86%)
GOOGL   156.45 (+0.63%)
AMZN   179.55 (-0.95%)
TSLA   150.45 (-3.22%)
NVDA   849.20 (+1.05%)
AMD   154.94 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.96 (+0.20%)
T   16.31 (+1.18%)
F   12.05 (+0.08%)
MU   112.52 (-3.28%)
GE   153.77 (-1.22%)
CGC   7.87 (+21.26%)
DIS   112.76 (-0.16%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.08 (-1.87%)
XOM   118.72 (+0.08%)
QQQ   423.38 (-0.58%)
AAPL   167.20 (-0.48%)
MSFT   405.19 (-1.61%)
META   503.38 (+1.86%)
GOOGL   156.45 (+0.63%)
AMZN   179.55 (-0.95%)
TSLA   150.45 (-3.22%)
NVDA   849.20 (+1.05%)
AMD   154.94 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.96 (+0.20%)
T   16.31 (+1.18%)
F   12.05 (+0.08%)
MU   112.52 (-3.28%)
GE   153.77 (-1.22%)
CGC   7.87 (+21.26%)
DIS   112.76 (-0.16%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.08 (-1.87%)
XOM   118.72 (+0.08%)

Biogen (BIIB) SEC Filings & 10K Form

$190.51
-1.65 (-0.86%)
(As of 03:58 PM ET)

Recent Biogen SEC Filings

DateFilerForm TypeView
04/12/2024
4:01 PM
Biogen (Filer)
Form PRE 14A
04/03/2024
7:24 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:11 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
9:08 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
6:54 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
9:12 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
8:31 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:33 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:36 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:39 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:27 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:28 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:29 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
9:24 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
8:13 PM
Biogen (Issuer)
Rowinsky Eric K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:56 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:00 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:01 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:03 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:04 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:06 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:14 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
6:07 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:07 PM
Biogen (Filed by)
Denali Therapeutics Inc. (Subject)
Form SC 13G/A
02/12/2024
6:11 PM
Biogen (Filed by)
SANGAMO THERAPEUTICS, INC (Subject)
Form SC 13G/A
02/12/2024
10:21 AM
Biogen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/12/2024
10:10 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
9:50 AM
Biogen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/09/2024
7:11 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:12 PM
Biogen (Issuer)
Grogan Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:14 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:16 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
6:56 PM
Biogen (Issuer)
Viehbacher Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
6:59 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:01 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:03 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:06 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:08 PM
Biogen (Issuer)
Keeney Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:38 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
9:44 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:34 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Nvidia Has a BIG Problem — Here’s Who Benefits MOST (Ad)

#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'

If You Missed Out On The AI Boom, Take These 3 Steps
01/31/2024
4:35 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:36 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:27 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:30 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:31 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:33 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
4:52 PM
Biogen (Issuer)
Patolawala Monish D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/12/2023
4:02 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
3:36 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
9:06 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2023
6:02 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
4:15 PM
Biogen (Issuer)
Grogan Jane (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/28/2023
4:25 PM
Biogen (Filer)
Form 8-K/A
09/28/2023
4:30 PM
Biogen (Reporting)
Biogen MA Inc. (Reporting)
SANGAMO THERAPEUTICS, INC (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2023
3:38 PM
Biogen (Filed by)
REATA PHARMACEUTICALS INC (Subject)
Form SC 13D/A
09/26/2023
4:25 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023
5:06 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
5:08 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
10:23 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
3:36 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2023
6:00 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2023
6:02 AM
Biogen (Filer)
Form DEFA14A
07/28/2023
6:11 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2023
6:13 AM
Biogen (Filer)
Form DEFA14A
07/25/2023
6:03 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
4:33 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:35 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:37 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
2:37 PM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2023
3:24 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2023
6:00 PM
Biogen (Issuer)
Freire Maria C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
6:01 PM
Biogen (Issuer)
HAWKINS WILLIAM A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
6:03 PM
Biogen (Issuer)
LANGER SUSAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/28/2023
6:04 PM
Biogen (Issuer)
LANGER SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
6:05 PM
Biogen (Issuer)
Mantas Jesus B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
6:06 PM
Biogen (Issuer)
Rowinsky Eric K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
6:10 PM
Biogen (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
5:59 PM
Biogen (Issuer)
DORSA CAROLINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
6:25 AM
Biogen (Filer)
Form DEFR14A
06/13/2023
6:28 AM
Biogen (Filer)
Form DEFA14A
05/03/2023
8:02 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2023
7:05 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
7:08 PM
Biogen (Issuer)
Keeney Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2023
4:23 PM
Biogen (Filer)
Form DEFA14A
04/28/2023
4:17 PM
Biogen (Filer)
Form ARS
04/28/2023
12:07 PM
Biogen (Subject)
Gregory Ginger (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/25/2023
3:45 PM
Biogen (Issuer)
Keeney Adam (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/25/2023
3:21 PM
Biogen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2023
3:21 PM
Biogen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2023
6:02 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Nvidia Has a BIG Problem — Here’s Who Benefits MOST (Ad)

#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'

If You Missed Out On The AI Boom, Take These 3 Steps
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BIIB) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners